Paradoxical results in the study of risk factors of chronic obstructive pulmonary disease (COPD) re-admission

被引:5
|
作者
Garcia-Aymerich, J
Marrades, RM
Monsó, E
Barreiro, E
Farrero, E
Antó, JM
机构
[1] IMIM, Resp & Environm Hlth Res Unit, E-08003 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain
[3] Hosp Germans Trias & Pujol, Dept Pneumol, Barcelona, Spain
[4] Hosp Mar, Dept Pneumol, Barcelona, Spain
[5] Ciudad Sanitaria & Univ Bellvitge, Hosp Llobregat, Dept Pneumol, Lhospitalet De Llobregat, Spain
[6] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
关键词
COPD; confounding by indication; confounding by severity; paradoxical results;
D O I
10.1016/j.rmed.2004.02.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously reported an apparently paradoxical association between medical care related factors and an increased risk of chronic obstructive pulmonary disease (COPD) re-hospitalisation, in a cohort of 346 COPD subjects from Barcelona, Spain. Confounding by severity or by indication is a plausible explanation. We tested the confounding effect of severity-related variables on these paradoxical associations. Forced expiratory volume in one second (FEV1), arterial oxygen pressure (PO2) and previous COPD admissions were associated with: (1) the presence of medical care related factors, and (2) re-admission during follow-up. Risks of readmission associated with most of the medical care related factors were reduced after adjustment for the severity variables. The risk associated with tong-term oxygen therapy use changed from a crude OR of 2.36 (95% CI: 1.79-3.11) to an adjusted OR of 1.38 (0.95-2.00), while that associated with anticholinergics use varied from 3.52 (2.37-5.21) to 2.10 (1.32-3.36)). We concluded that the excess risk of COPD re-admission associated with medical care related factors might be partially due to confounding by indication. Residual confounding may still account for part of the remaining excess risk. True adverse effects of some pharmacological treatments cannot be excluded. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:851 / 857
页数:7
相关论文
共 50 条
  • [21] HOSPITAL RE-ADMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - WHAT ARE THE RISK FACTORS?
    Patel, Rajan
    Fromson, Renate
    Routledge, Emma
    Johnson, Emma
    Jameie-Oskooei, Sina
    Blad, William
    Moledina, Saadiq
    Wong, Voishim
    GASTROENTEROLOGY, 2020, 158 (03) : S81 - S81
  • [22] HOSPITAL RE-ADMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - WHAT ARE THE RISK FACTORS?
    Patel, Rajan
    Fromson, Renate
    Routledge, Emma
    Johnson, Emma
    Jameie-Oskooei, Sina
    Blad, William
    Moledina, Saadiq
    Wong, Voishim
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S50 - S50
  • [23] Re-admission from OPAT: Risk factors and outcome
    Lye, D. C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S36 - S36
  • [24] Limitation of Inspiratory and Expiratory Flow and Re-Admission Risk at Exacerbation of COPD
    Alqahtani, J. S.
    Quaderi, S.
    Aldhahir, A. M.
    Mandal, S.
    Hurst, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] The Heterogeneity of Prevalence and Risk Factors for Chronic Obstructive Pulmonary Disease (COPD) in the Canadian Urban Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
    Leung, C.
    Bourbeau, J.
    Sin, D.
    Aaron, S. D.
    Fitzgerald, J. M.
    Maltais, F.
    Marciniuk, D. D.
    O'Donnell, D. E.
    Hernandez, P.
    Chapman, K. R.
    Walker, B.
    Road, J. D.
    Zheng, L.
    Zou, L. X.
    Hogg, J. C.
    Tan, W. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [26] Re-admission and quality of life among patients with chronic obstructive pulmonary disease after telemedicine video nursing consultation- a randomized study
    Saleh, Safaa
    Skeie, Svein
    Grundt, Heidi
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2023, 18 : 51 - 58
  • [27] The prevalence of chronic obstructive pulmonary disease (COPD) in Germany: results of the BOLD Study
    Geldmacher, H.
    Biller, H.
    Herbst, A.
    Urbanski, K.
    Allison, M.
    Buist, A. S.
    Hohlfeld, J. M.
    Welte, T.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (50) : 2609 - 2614
  • [28] Pneumothorax Risk Factors In Smokers With And Without Chronic Obstructive Pulmonary Disease (COPD) From The COPDgene Study
    Hobbs, B. D.
    Foreman, M. G.
    Bowler, R. P.
    Jacobson, F.
    Make, B. J.
    Silverman, E. K.
    Hersh, C. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [29] Nutritional risk factors for the development of chronic obstructive pulmonary disease (COPD) in male smokers
    Celik, Fatma
    Topcu, Fusun
    CLINICAL NUTRITION, 2006, 25 (06) : 955 - 961
  • [30] Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors
    Montserrat-Capdevila, Josep
    Asuncion Seminario, Maria
    Godoy, Pere
    Ramon Marsal, Josep
    Ortega, Marta
    Pujol, Jesus
    Teresa Castan, Maria
    Alseda, Miguel
    Betriu, Angels
    Lecube, Albert
    Portero, Manel
    Purroy, Francisco
    Manuel Valdivielso, Jose
    Barbe, Ferran
    MEDICINA CLINICA, 2018, 151 (10): : 383 - 389